Large Cap Biopharmaceuticals: Provide Growth, Value And Yield By: TalkMarkets May 16, 2022 at 06:00 AM EDT Now that all major biopharmaceutical earnings are in, we can review the financial metrics and see if our portfolio needs re-balancing. Read More >> Related Stocks: AbbVie Astrazeneca Plc ADR Bristol-Myers Squibb Gilead Sciences Gsk Plc ADR Merck & Co Pfizer Regeneron Pharmaceuticals S&P Biotech SPDR Seagen Inc Vertex Pharmaceuticals
